3
Announcements
Trials
Browse
Landscape
Status
Completed
11
Terminated
6
Active not recruiting
3
Recruiting
2
Unknown
1
Not yet recruiting
1
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Imatinib Mesylate
2
nilotinib
1
flumatinib
1
bosutinib
1
asciminib
1
Dasatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Leukemia, Myeloid, Chronic-Phase
×
nilotinib
×
Clear all
NCT07091019
2025-07-29
ASC4REAL-2
Novartis
Not yet recruiting
1,000 enrolled